| Parameters . | Survivor (n = 48) . | Nonsurvivor (n = 43) . | P value . |
|---|---|---|---|
| Sex | |||
| Male | 26 (54.2%) | 24 (55.8%) | 0.875a |
| Female | 22 (45.8%) | 19 (44.2%) | |
| Age, years | 75 (65–84) | 71 (63–84) | 0.247b |
| BMI, kg/m2 | 24.6 (23.3–27.8) | 25.95 (22.8–31.2) | 0.209b |
| Comorbid diseases | |||
| Cardiovascular disease | 26 (54.2%) | 22 (51.2%) | 0.774a |
| Diabetes mellitus | 16 (33.3%) | 21 (48.8%) | 0.133a |
| Hypertension | 43 (89.6%) | 30 (69.8%) | 0.018a |
| Chronic lung disease | 13 (27.1%) | 10 (23.3 %) | 0.675a |
| Number of comorbid diseases | |||
| 1 | 8 (16.7%) | 8 (16.7%) | 0.808a |
| 2 | 32 (66.7%) | 30 (69.8%) | 0.751a |
| 3 | 7 (14.6%) | 5 (11.6%) | 0.677a |
| 4 | 1 (2.1%) | 0 | 0.341a |
| Glucose, mg/dl | 145 (116–234) | 172 (137–238) | 0.061b |
| Urea, mg/dl | 54 (42–71) | 60 (39–73) | 0.877b |
| Creatine, mg/dl | 1 (0.81–1.22) | 1 (0.8–1.38) | 0.937b |
| Sodium, mmol/l | 137 (133–139) | 138 (134–142) | 0.232b |
| Potassium, mmol/l | 3.92 (3.34–4.43) | 4.2 (3.54–4.6) | 0.180b |
| AST, U/l | 26 (18–58) | 27 (23–43) | 0.946b |
| ALT, U/l | 18 (12–27) | 18 (15–24) | 0.696b |
| Albumin, g/dl | 2.77 (2.5–3.2) | 2.75 (2.53–2.99) | 0.382b |
| CRP, mg/dl | 7.41 (2.1–12.5) | 9.9 (3.8–16) | 0.278b |
| D-dimer, ug/l | 1446 (849–2320) | 1610 (923–3380) | 0.373b |
| Arterial blood gas analysis | |||
| pH | 7.39 (7.37–7.45) | 7.40 (7.33–7.45) | 0.349b |
| pCO2, mmHg | 39 (32–42) | 36 (34–45) | 0.656b |
| HCO3−, mmol/l | 24 (22–25) | 22 (20–25) | 0.044b |
| ONSD, mm | 4.15 (4.06–4.25) | 5.95 (5.8–6.25) | <0.001b |
| APACHE II score | 8 (8–9) | 12 (10–15) | <0.001b |
| SOFA score | 2 (2–2) | 3 (3–4) | <0.001b |
| GCS score | 15 (15–15) | 14 (11–15) | <0.001b |
| PaO2:FiO2 ratio, mmHg | 227 (200–250) | 130 (120–160) | <0.001b |
| IMV | 9 (19%) | 32 (74%) | <0.001a |
| NIV | 39 (81.3%) | 11 (25.6%) | |
| Length of ICU stay, day | 4 (3–9) | 8 (6–14) | <0.001b |
| Parameters . | Survivor (n = 48) . | Nonsurvivor (n = 43) . | P value . |
|---|---|---|---|
| Sex | |||
| Male | 26 (54.2%) | 24 (55.8%) | 0.875a |
| Female | 22 (45.8%) | 19 (44.2%) | |
| Age, years | 75 (65–84) | 71 (63–84) | 0.247b |
| BMI, kg/m2 | 24.6 (23.3–27.8) | 25.95 (22.8–31.2) | 0.209b |
| Comorbid diseases | |||
| Cardiovascular disease | 26 (54.2%) | 22 (51.2%) | 0.774a |
| Diabetes mellitus | 16 (33.3%) | 21 (48.8%) | 0.133a |
| Hypertension | 43 (89.6%) | 30 (69.8%) | 0.018a |
| Chronic lung disease | 13 (27.1%) | 10 (23.3 %) | 0.675a |
| Number of comorbid diseases | |||
| 1 | 8 (16.7%) | 8 (16.7%) | 0.808a |
| 2 | 32 (66.7%) | 30 (69.8%) | 0.751a |
| 3 | 7 (14.6%) | 5 (11.6%) | 0.677a |
| 4 | 1 (2.1%) | 0 | 0.341a |
| Glucose, mg/dl | 145 (116–234) | 172 (137–238) | 0.061b |
| Urea, mg/dl | 54 (42–71) | 60 (39–73) | 0.877b |
| Creatine, mg/dl | 1 (0.81–1.22) | 1 (0.8–1.38) | 0.937b |
| Sodium, mmol/l | 137 (133–139) | 138 (134–142) | 0.232b |
| Potassium, mmol/l | 3.92 (3.34–4.43) | 4.2 (3.54–4.6) | 0.180b |
| AST, U/l | 26 (18–58) | 27 (23–43) | 0.946b |
| ALT, U/l | 18 (12–27) | 18 (15–24) | 0.696b |
| Albumin, g/dl | 2.77 (2.5–3.2) | 2.75 (2.53–2.99) | 0.382b |
| CRP, mg/dl | 7.41 (2.1–12.5) | 9.9 (3.8–16) | 0.278b |
| D-dimer, ug/l | 1446 (849–2320) | 1610 (923–3380) | 0.373b |
| Arterial blood gas analysis | |||
| pH | 7.39 (7.37–7.45) | 7.40 (7.33–7.45) | 0.349b |
| pCO2, mmHg | 39 (32–42) | 36 (34–45) | 0.656b |
| HCO3−, mmol/l | 24 (22–25) | 22 (20–25) | 0.044b |
| ONSD, mm | 4.15 (4.06–4.25) | 5.95 (5.8–6.25) | <0.001b |
| APACHE II score | 8 (8–9) | 12 (10–15) | <0.001b |
| SOFA score | 2 (2–2) | 3 (3–4) | <0.001b |
| GCS score | 15 (15–15) | 14 (11–15) | <0.001b |
| PaO2:FiO2 ratio, mmHg | 227 (200–250) | 130 (120–160) | <0.001b |
| IMV | 9 (19%) | 32 (74%) | <0.001a |
| NIV | 39 (81.3%) | 11 (25.6%) | |
| Length of ICU stay, day | 4 (3–9) | 8 (6–14) | <0.001b |
Categorical data shown as number (percentage). Non-normally distributed continuous variables displayed as median (interquartile range). P < 0.05: significant (shown in bold).
BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CRP, C-reactive protein; pH, potential of hydrogen; PCO2, carbon dioxide arterial partial pressure; HCO3−, bicarbonate; ONSD, optic nerve sheath diameter; APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; GCS, Glasgow Coma Scale; PaO2:FiO2, arterial blood gas and arterial partial pressure of oxygen:fraction of inspired oxygen; IMV, invasive mechanical ventilation; NIV, non-invasive mechanical ventilation; ICU, intensive care unit.
Chi-square test,.
Mann–Whitney’s test.
| Parameters . | Survivor (n = 48) . | Nonsurvivor (n = 43) . | P value . |
|---|---|---|---|
| Sex | |||
| Male | 26 (54.2%) | 24 (55.8%) | 0.875a |
| Female | 22 (45.8%) | 19 (44.2%) | |
| Age, years | 75 (65–84) | 71 (63–84) | 0.247b |
| BMI, kg/m2 | 24.6 (23.3–27.8) | 25.95 (22.8–31.2) | 0.209b |
| Comorbid diseases | |||
| Cardiovascular disease | 26 (54.2%) | 22 (51.2%) | 0.774a |
| Diabetes mellitus | 16 (33.3%) | 21 (48.8%) | 0.133a |
| Hypertension | 43 (89.6%) | 30 (69.8%) | 0.018a |
| Chronic lung disease | 13 (27.1%) | 10 (23.3 %) | 0.675a |
| Number of comorbid diseases | |||
| 1 | 8 (16.7%) | 8 (16.7%) | 0.808a |
| 2 | 32 (66.7%) | 30 (69.8%) | 0.751a |
| 3 | 7 (14.6%) | 5 (11.6%) | 0.677a |
| 4 | 1 (2.1%) | 0 | 0.341a |
| Glucose, mg/dl | 145 (116–234) | 172 (137–238) | 0.061b |
| Urea, mg/dl | 54 (42–71) | 60 (39–73) | 0.877b |
| Creatine, mg/dl | 1 (0.81–1.22) | 1 (0.8–1.38) | 0.937b |
| Sodium, mmol/l | 137 (133–139) | 138 (134–142) | 0.232b |
| Potassium, mmol/l | 3.92 (3.34–4.43) | 4.2 (3.54–4.6) | 0.180b |
| AST, U/l | 26 (18–58) | 27 (23–43) | 0.946b |
| ALT, U/l | 18 (12–27) | 18 (15–24) | 0.696b |
| Albumin, g/dl | 2.77 (2.5–3.2) | 2.75 (2.53–2.99) | 0.382b |
| CRP, mg/dl | 7.41 (2.1–12.5) | 9.9 (3.8–16) | 0.278b |
| D-dimer, ug/l | 1446 (849–2320) | 1610 (923–3380) | 0.373b |
| Arterial blood gas analysis | |||
| pH | 7.39 (7.37–7.45) | 7.40 (7.33–7.45) | 0.349b |
| pCO2, mmHg | 39 (32–42) | 36 (34–45) | 0.656b |
| HCO3−, mmol/l | 24 (22–25) | 22 (20–25) | 0.044b |
| ONSD, mm | 4.15 (4.06–4.25) | 5.95 (5.8–6.25) | <0.001b |
| APACHE II score | 8 (8–9) | 12 (10–15) | <0.001b |
| SOFA score | 2 (2–2) | 3 (3–4) | <0.001b |
| GCS score | 15 (15–15) | 14 (11–15) | <0.001b |
| PaO2:FiO2 ratio, mmHg | 227 (200–250) | 130 (120–160) | <0.001b |
| IMV | 9 (19%) | 32 (74%) | <0.001a |
| NIV | 39 (81.3%) | 11 (25.6%) | |
| Length of ICU stay, day | 4 (3–9) | 8 (6–14) | <0.001b |
| Parameters . | Survivor (n = 48) . | Nonsurvivor (n = 43) . | P value . |
|---|---|---|---|
| Sex | |||
| Male | 26 (54.2%) | 24 (55.8%) | 0.875a |
| Female | 22 (45.8%) | 19 (44.2%) | |
| Age, years | 75 (65–84) | 71 (63–84) | 0.247b |
| BMI, kg/m2 | 24.6 (23.3–27.8) | 25.95 (22.8–31.2) | 0.209b |
| Comorbid diseases | |||
| Cardiovascular disease | 26 (54.2%) | 22 (51.2%) | 0.774a |
| Diabetes mellitus | 16 (33.3%) | 21 (48.8%) | 0.133a |
| Hypertension | 43 (89.6%) | 30 (69.8%) | 0.018a |
| Chronic lung disease | 13 (27.1%) | 10 (23.3 %) | 0.675a |
| Number of comorbid diseases | |||
| 1 | 8 (16.7%) | 8 (16.7%) | 0.808a |
| 2 | 32 (66.7%) | 30 (69.8%) | 0.751a |
| 3 | 7 (14.6%) | 5 (11.6%) | 0.677a |
| 4 | 1 (2.1%) | 0 | 0.341a |
| Glucose, mg/dl | 145 (116–234) | 172 (137–238) | 0.061b |
| Urea, mg/dl | 54 (42–71) | 60 (39–73) | 0.877b |
| Creatine, mg/dl | 1 (0.81–1.22) | 1 (0.8–1.38) | 0.937b |
| Sodium, mmol/l | 137 (133–139) | 138 (134–142) | 0.232b |
| Potassium, mmol/l | 3.92 (3.34–4.43) | 4.2 (3.54–4.6) | 0.180b |
| AST, U/l | 26 (18–58) | 27 (23–43) | 0.946b |
| ALT, U/l | 18 (12–27) | 18 (15–24) | 0.696b |
| Albumin, g/dl | 2.77 (2.5–3.2) | 2.75 (2.53–2.99) | 0.382b |
| CRP, mg/dl | 7.41 (2.1–12.5) | 9.9 (3.8–16) | 0.278b |
| D-dimer, ug/l | 1446 (849–2320) | 1610 (923–3380) | 0.373b |
| Arterial blood gas analysis | |||
| pH | 7.39 (7.37–7.45) | 7.40 (7.33–7.45) | 0.349b |
| pCO2, mmHg | 39 (32–42) | 36 (34–45) | 0.656b |
| HCO3−, mmol/l | 24 (22–25) | 22 (20–25) | 0.044b |
| ONSD, mm | 4.15 (4.06–4.25) | 5.95 (5.8–6.25) | <0.001b |
| APACHE II score | 8 (8–9) | 12 (10–15) | <0.001b |
| SOFA score | 2 (2–2) | 3 (3–4) | <0.001b |
| GCS score | 15 (15–15) | 14 (11–15) | <0.001b |
| PaO2:FiO2 ratio, mmHg | 227 (200–250) | 130 (120–160) | <0.001b |
| IMV | 9 (19%) | 32 (74%) | <0.001a |
| NIV | 39 (81.3%) | 11 (25.6%) | |
| Length of ICU stay, day | 4 (3–9) | 8 (6–14) | <0.001b |
Categorical data shown as number (percentage). Non-normally distributed continuous variables displayed as median (interquartile range). P < 0.05: significant (shown in bold).
BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CRP, C-reactive protein; pH, potential of hydrogen; PCO2, carbon dioxide arterial partial pressure; HCO3−, bicarbonate; ONSD, optic nerve sheath diameter; APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; GCS, Glasgow Coma Scale; PaO2:FiO2, arterial blood gas and arterial partial pressure of oxygen:fraction of inspired oxygen; IMV, invasive mechanical ventilation; NIV, non-invasive mechanical ventilation; ICU, intensive care unit.
Chi-square test,.
Mann–Whitney’s test.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
